Furthermore, in models of NSCLC, GAN was reported to efficiently ameliorate several oncogenic factors and downregulate the expression of MAPK/AKT signaling to instigate apoptosis [32]. The gene discussed is GAN; the disease is non-small cell lung carcinoma.